DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/x8tttc/global_sickle) has announced the addition of the "Global Sickle Cell Anaemia Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Sickle Cell Anaemia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Sickle Cell Anaemia market. It covers active Sickle Cell Anaemia pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Sickle Cell Anaemia - Disease Overview
2. Sickle Cell Anaemia Pipeline Overview
3. Sickle Cell Anaemia Phase 3 Clinical Trial Pipeline Insights
4. Sickle Cell Anaemia Phase 2 Clinical Trial Pipeline Insights
5. Sickle Cell Anaemia Phase 1 Clinical Trial Pipeline Insights
6. Sickle Cell Anaemia Preclinical Research Pipeline Insights
7. Sickle Cell Anaemia Discovery Stage Pipeline Insights
8. Sickle Cell Anaemia Drug Development Activities - Geographic Landscape
8.1. Sickle Cell Anaemia R&D Activities in North America
8.2. Sickle Cell Anaemia R&D Activities in Europe
9. Sickle Cell Anaemia Pipeline - Licensing Activities
Table 1. Sickle Cell Anaemia Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Sickle Cell Anaemia Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Sickle Cell Anaemia Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Sickle Cell Anaemia Pipeline Molecules - Preclinical Research
Table 5. Sickle Cell Anaemia Pipeline Molecules - Drug Discovery
Table 6. Sickle Cell Anaemia R&D Activities by Geography
Table 7. Sickle Cell Anaemia Pipeline Molecules - North America
Table 8. Sickle Cell Anaemia Pipeline Molecules - Europe
Table 9. Sickle Cell Anaemia Pipeline - Licensing Activities
Figure 1. Sickle Cell Anaemia Pipeline Molecules by R&D Stage
Figure 2. Sickle Cell Anaemia R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/x8tttc/global_sickle